Financial statements Elanda Pharma
Cash flow statement of Elanda Pharma
Company age:
Age:
7 y. 4 m. 1 d.
Share capital:
Share capital:
500 000 PLN
Cash inflows of ELANDA PHARMA
|
Year
|
2018
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Net cash from operating expenses | - | - | - | -146 532,39 |
| Net cash flow from investing activities | - | - | - | -1 447 862,33 |
| Net cash flow from financial activities | - | - | - | 1 598 148,98 |
| Total net cash flow | - | - | - | 3 754,26 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.